System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Yi-Jen Chen is an expert in Oncology at Wan Fang Hospital (Taiwan). As of October 2026, ScienceLeadR ranks Yi-Jen Chen in the top 1% of experts worldwide for Atrial Fibrillation and Arrhythmias, Cardiac. Yi-Jen Chen has authored 642 publications, the most recent in 2026, and is an investigator in 16 clinical trials, 3 of them ongoing. SLR score: 2,169 (community average: 125). How the SLR is computed.

LeadR Profile

Yi-Jen Chen Wan Fang Hospital Taiwan
2 169 ScienceLeadR Reputation 2169

Unlock

Register Login
Network Map

Oncology

Subspecialties: Biochemistry - Gynecology - Obstetrics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1985 - 2026
Source: PubMed

Wan Fang Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 642

Citations

Citations: 25 468 1st author: 48 Last author: 248 Unique author: 3

Main journals

Int J Cardiol 37
Taiwan J Obstet Gynecol 37
J Natl Compr Canc Netw 30
J Cardiovasc Electrophysiol 29
J Chin Med Assoc 28

Best Journals

J Clin Oncol 4
Eur Heart J 1
Lancet Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Finerenone mitigates acute alcoholic myocardial injury by modulating inflammatory signaling, oxidative stress, and mitochondrial function.
PMID 42323566 — cells, aldosterone, molecular biology, heart, stress, physiological, oxidative stress, alcoholics, clinical medicine, cardiotoxicity, ethanol, apoptosis, cell death, myocytes, cardiac		Mol Med20260
Glucose-dependent insulinotropic polypeptide receptor agonism improves heart failure with antifibrosis through Akt-dependent nitric oxide signaling.
PMID 42675474 — arginine, fibrosis, heart failure, heart, collagen, fibroblasts		J Biomed Sci20260
Therapeutic Lithium Enhances Klotho Expression and Mitochondrial Size and Branching in Human Cardiac Fibroblasts Involving Nuclear Factor-kappa B Inhibition.
PMID 42528353 — mania, mitochondrial size, nf-kappa b, fibroblasts, therapeutics, tissues		Clin Psychopharmacol Neurosci20261
Human epidermal growth factor receptor-2, nectin-4, and trophoblast cell surface antigen-2 expression varies significantly across ovarian cancer histotypes.
PMID 42362263 — cells, epidermal growth factor, trophoblasts, growth, antigens, surface, nectins, ovary, neoplasms, receptors, growth factor, ovarian neoplasms		Taiwan J Obstet Gynecol20260
Real-time intraoperative identification of malignant ovarian tumors using deep learning of clinical gross specimen images.
PMID 42362266 — area under curve, mental recall, ovary, neoplasms, deep learning, physicians, learning		Taiwan J Obstet Gynecol20260

Clinical Studies 16

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4 Study Chair: 6 Study Director: 1

By phase:

N/A 7
Phase 3 5
Phase 1 2
Early Phase 1 1
Phase 2 1

By status:

Unknown 7
Completed 4
Active not recruiting 2
Recruiting 2
Suspended 1

By type:

Interventional 15
Observational 1

By Monocentric/Multicentric:

monocentric 13
multicentric2to4 0
multicentric5to9 0
multicentricup10 3

Main Topics

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
PVX4 for the Treatment of Human Papilloma Virus (HPV)16 Cervical Dysplasia
NCT07454915 — injections, saline solution, vaccines, neoplasms, papilloma, human papillomavirus 16, uterine cervical dysplasia, viruses, therapeutics, injections, intramuscular, dna, electroporation, infections, vaccines, dna, virus diseases, human papillomavirus viruses		Phase 2Recruiting2026
Spatiotemporal Stereotactic Body Radiation Therapy for the Treatment of Patients With Polymetastatic Solid Tumors
NCT05733949 — radiotherapy, pilot projects, pilots, blood, radiosurgery, tomography, neoplasms, neoplasm metastasis, specimen handling, therapeutics		Early Phase 1Recruiting2023
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma
NCT05323253 — radiotherapy, skin, cells, safety, carcinoma, squamous cell, brachytherapy, neoplasms, seeds, therapeutics, skin neoplasms, carcinoma, cutaneous squamous cell carcinoma		N/AActive not recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS